Form 8-K Cyclacel Pharmaceuticals For: May 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Cyclacel Pharma (CYCC) Posts Wider Q1 Loss
May 12, 2021 4:25 PM EDTCyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($1.48), $0.99 worse than the analyst estimate of ($0.49).
During the quarter, we have made significant progress in bringing our two oral targeted development candidates into mid-stage clinical development. Following recent FDA authorization of our IND for oral... More
